Abuse of medications employed for the treatment of ADHD: results from a large-scale community survey
- PMID: 18596945
- PMCID: PMC2438483
Abuse of medications employed for the treatment of ADHD: results from a large-scale community survey
Abstract
Objective: The objective is to assess abuse of prescription and illicit stimulants among individuals being treated for attention-deficit/hyperactivity disorder (ADHD).
Methods: A survey was distributed to patients enrolled in an ADHD treatment center. It included questions designed to gain information about demographics; ADHD treatment history; illicit drug use; and misuse of prescribed stimulant medications, including type of stimulant medication most frequently misused or abused, and how the stimulant was prepared and administered.
Results: A total of 545 subjects (89.2% with ADHD) were included in the survey. Results indicated that 14.3% of respondents abused prescription stimulants. Of these, 79.8% abused short-acting agents; 17.2% abused long-acting stimulants; 2.0% abused both short- and long-acting agents; and 1.0% abused other agents. The specific medications abused most often were mixed amphetamine salts (Adderall; 40.0%), mixed amphetamine salts extended release (Adderall XR; 14.2%), and methylphenidate (Ritalin; 15.0%), and the most common manner of stimulant abuse was crushing pills and snorting (75.0%). Survey results also showed that 39.1% of respondents used nonprescription stimulants, most often cocaine (62.2%), methamphetamine (4.8%), and both cocaine and amphetamine (31.1%). Choice of illicit drug was based on rapidity of high onset (43.5%), ease of acquisition (40.7%), ease of use (10.2%), and cost (5.5%).
Conclusions: The risks for abuse of prescription and illicit stimulants are elevated among individuals being treated in an ADHD clinic. Prescription agents used most often are those with pharmacologic and pharmacokinetic characteristics that provide a rapid high. This suggests that long-acting stimulant preparations that have been developed for the treatment of ADHD may have lower abuse potential than short-acting formulations.
Figures
Similar articles
-
The potential for misuse and abuse of medications in ADHD: a review.Postgrad Med. 2014 Sep;126(5):64-81. doi: 10.3810/pgm.2014.09.2801. Postgrad Med. 2014. PMID: 25295651 Review.
-
ADHD medication use, adherence, persistence and cost among Texas Medicaid children.Curr Med Res Opin. 2011;27 Suppl 2:13-22. doi: 10.1185/03007995.2011.603303. Curr Med Res Opin. 2011. PMID: 21973228
-
Nonmedical use of prescription ADHD stimulant medications among adults in a substance abuse treatment population: early findings from the NAVIPPRO surveillance system.J Atten Disord. 2015 Apr;19(4):275-83. doi: 10.1177/1087054713493321. Epub 2013 Jul 30. J Atten Disord. 2015. PMID: 23900405
-
Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Clin Ther. 2008. PMID: 18555941 Review.
-
ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.J Atten Disord. 2008 Sep;12(2):115-25. doi: 10.1177/1087054707311654. Epub 2008 Jan 11. J Atten Disord. 2008. PMID: 18192623 Review.
Cited by
-
Stimulant prescription cautions: addressing misuse, diversion and malingering.Curr Psychiatry Rep. 2013 Jul;15(7):375. doi: 10.1007/s11920-013-0375-2. Curr Psychiatry Rep. 2013. PMID: 23712725 Review.
-
The Dopamine Dilemma-Part II: Could Stimulants Cause Tolerance, Dependence, and Paradoxical Decompensation?Innov Clin Neurosci. 2011 Jan;8(1):47-53. Innov Clin Neurosci. 2011. PMID: 21311708 Free PMC article.
-
Exploring the Behavior of Users With Attention-Deficit/Hyperactivity Disorder on Twitter: Comparative Analysis of Tweet Content and User Interactions.J Med Internet Res. 2023 May 17;25:e43439. doi: 10.2196/43439. J Med Internet Res. 2023. PMID: 37195757 Free PMC article.
-
Methylphenidate for Attention-Deficit and Hyperactivity Disorder in Adult Patients With Substance Use Disorders: Good Clinical Practice.Front Psychiatry. 2021 Jan 26;11:540837. doi: 10.3389/fpsyt.2020.540837. eCollection 2020. Front Psychiatry. 2021. PMID: 33574770 Free PMC article. Review.
-
Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review.Front Psychiatry. 2024 Nov 18;15:1508732. doi: 10.3389/fpsyt.2024.1508732. eCollection 2024. Front Psychiatry. 2024. PMID: 39624511 Free PMC article.
References
-
- Greenhill LL. The science of stimulant abuse. Pediatr Ann. 2006;35:552–556. - PubMed
-
- Zito JM, Safer DJ, dos Reis S, Gardner JF, Boles M, Lynch F. Trends in the prescribing of psychotropic medications to preschoolers. JAMA. 2000;283:1025–1030. - PubMed
-
- Greenhill LL, Pliszka S, Dulcan MK, et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2002;41(suppl):26S–49S. - PubMed
-
- Lin SJ, Crawford SY, Lurvey PL. Trend and area variation in amphetamine prescription usage among children and adolescents in Michigan. Soc Sci Med. 2005;60:617–626. - PubMed
-
- Connor DF, Steingard RJ. New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential. CNS Drugs. 2004;18:1011–1030. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical